WIPF1 knockdown in glioblastoma and breast cancer cells expressing mtp53 greatly reduced the proliferation and growth capacity of cancer stem cell-like cells and reduced the expression of cancer stem cell-like markers (CD44, CD133 or TAZ/YAP). Here, PROM1 is linked to breast cancer.